Emergent BioSolutions Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	676.8	742.9	1,044	1,049	1,118	1,774
Revenue Growth (YoY)	-29.89%	-28.81%	-0.54%	-6.10%	-36.99%	12.45%
Cost of Revenue	309.7	326.2	681.3	705.4	693.1	748.1
Gross Profit	367.1	416.7	362.3	343.9	424.4	1,026
Selling, General & Admin	180.3	186.1	308	368.4	339.5	348.7
Depreciation & Amortization Expenses	65.3	65.1	65.1	65.6	59.9	58.5
Research & Development	48.6	53.2	70.7	111.4	188.3	235.2
Other Operating Expenses	12.2	12.2	27.2	524.9	6.7	41.7
Total Operating Expenses	306.4	316.6	471	1,070	594.4	684.1
Operating Income	60.7	100.1	-108.7	-726.4	-170	341.4
Interest Expense	-55.6	-59.3	-71	-87.9	-37.3	-34.5
Other Non-Operating Income (Expense)	25	66.4	36.8	83.1	-11.7	-3.7
Total Non-Operating Income (Expense)	-30.6	7.1	-34.2	-4.8	-49	-38.2
Pretax Income	3.5	82.8	-142.9	-731.2	-219	303.2
Provision for Income Taxes	5.7	30.2	47.7	29.3	-7.4	83.7
Net Income	-8.6	52.6	-190.6	-760.5	-211.6	219.5
Net Income to Common	-8.6	52.6	-190.6	-760.5	-211.6	219.5
Net Income Growth	-	-	-	-	-	-28.22%
Shares Outstanding (Basic)	53	54	53	51	50	54
Shares Outstanding (Diluted)	55	57	53	51	50	54
Shares Change (YoY)	-0.05%	6.98%	3.52%	2.20%	-7.39%	0.56%
EPS (Basic)	-0.17	0.98	-3.60	-14.85	-4.22	4.10
EPS (Diluted)	-0.28	0.93	-3.60	-14.85	-4.22	4.06
EPS Growth	-	-	-	-	-	-28.52%
Shares Outstanding	51.8	52.1	54.18	52.2	50.1	51.3
Free Cash Flow	135.4	156.8	35.8	-257.9	-149.9	96.1
Free Cash Flow Growth	-13.65%	337.99%	-	-	-	-75.67%
Free Cash Flow Per Share	2.47	2.77	0.68	-5.04	-2.99	1.78
Gross Margin	54.24%	56.09%	34.72%	32.77%	37.98%	57.82%
Operating Margin	8.97%	13.47%	-10.42%	-69.23%	-15.21%	19.25%
Profit Margin	-1.27%	7.08%	-18.26%	-72.48%	-18.94%	12.38%
FCF Margin	20.01%	21.11%	3.43%	-24.58%	-13.41%	5.42%
EBITDA	163.9	205.7	7.5	-580	-22.6	469.3
EBITDA Margin	24.22%	27.69%	0.72%	-55.27%	-2.02%	26.46%
EBIT	60.7	100.1	-108.7	-726.4	-170	341.4
EBIT Margin	8.97%	13.47%	-10.42%	-69.23%	-15.21%	19.25%
Effective Tax Rate	162.86%	36.47%	-33.38%	-4.01%	3.38%	27.61%

Updated Apr 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q